Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Colecalciferol, ohne Rx-Sortiment, ATC A11CC05

Conclusion of non-exclusive discount contracts according to §§ 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the aforementioned active substance within the period from 01.10.2026 to 30.09.2028 with the possibility of concluding the contract at any time (open-house model). In the open-house procedure, medicinal products according to the BfArM list under § 35 Paragraph 5a SGB V (paediatric medicinal products) are excluded.